Handelsbanken Fonder’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,800
| Closed | -$110K | – | 1541 |
|
|
2025
Q1 | $110K | Hold |
10,800
| – | – | ﹤0.01% | 1517 |
|
|
2024
Q4 | $171K | Buy |
10,800
+1,100
| +11% | +$17.4K | ﹤0.01% | 1522 |
|
|
2024
Q3 | $563K | Buy |
9,700
+1,700
| +21% | +$98.7K | ﹤0.01% | 1198 |
|
|
2024
Q2 | $366K | Buy |
8,000
+1,300
| +19% | +$59.5K | ﹤0.01% | 1298 |
|
|
2024
Q1 | $444K | Hold |
6,700
| – | – | ﹤0.01% | 1214 |
|
|
2023
Q4 | $266K | Hold |
6,700
| – | – | ﹤0.01% | 1428 |
|
|
2023
Q3 | $214K | Hold |
6,700
| – | – | ﹤0.01% | 1448 |
|
|
2023
Q2 | $269K | Sell |
6,700
-600
| -8% | -$24.1K | ﹤0.01% | 1384 |
|
|
2023
Q1 | $312K | Hold |
7,300
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q4 | $351K | Buy |
+7,300
| New | +$351K | ﹤0.01% | 1160 |
|
|
2022
Q2 | – | Sell |
-7,400
| Closed | -$402K | – | 1658 |
|
|
2022
Q1 | $402K | Hold |
7,400
| – | – | ﹤0.01% | 1350 |
|
|
2021
Q4 | $433K | Buy |
+7,400
| New | +$433K | ﹤0.01% | 1449 |
|